Marianne P. Allen

Array ( [id] => 4508804 [patent_doc_number] => 07915385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Sodium channel protein type III α-subunit splice variant' [patent_app_type] => utility [patent_app_number] => 12/416777 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23506 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915385.pdf [firstpage_image] =>[orig_patent_app_number] => 12416777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380236 [patent_doc_number] => 20090192075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Amylin Formulations' [patent_app_type] => utility [patent_app_number] => 12/410754 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4622 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192075.pdf [firstpage_image] =>[orig_patent_app_number] => 12410754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846254 [patent_doc_number] => 08455435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Remedies for ischemia' [patent_app_type] => utility [patent_app_number] => 12/410209 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 55 [patent_no_of_words] => 36203 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12410209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6066365 [patent_doc_number] => 20110202281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'ADAPTIVE BIOCHEMICAL SIGNATURES' [patent_app_type] => utility [patent_app_number] => 12/933381 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20868 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20110202281.pdf [firstpage_image] =>[orig_patent_app_number] => 12933381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6423417 [patent_doc_number] => 20100167987 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-07-01 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS' [patent_app_type] => utility [patent_app_number] => 12/404622 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23484 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0167/20100167987.pdf [firstpage_image] =>[orig_patent_app_number] => 12404622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6423417 [patent_doc_number] => 20100167987 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-07-01 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS' [patent_app_type] => utility [patent_app_number] => 12/404622 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23484 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0167/20100167987.pdf [firstpage_image] =>[orig_patent_app_number] => 12404622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495802 [patent_doc_number] => 20090263830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'VISUALIZATION AND QUANTITIATION OF CELLULAR CYTOTOXICITY USING CELL-PERMEABLE FLUOROGENIC PROTEASE SUBSTRATES AND CASPASE ACTIVITY INDICATOR MARKERS' [patent_app_type] => utility [patent_app_number] => 12/396736 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14861 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263830.pdf [firstpage_image] =>[orig_patent_app_number] => 12396736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385767 [patent_doc_number] => 20090227012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Human CDR-Grafted Antibody and Antibody Fragment Thereof' [patent_app_type] => utility [patent_app_number] => 12/395214 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 28628 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227012.pdf [firstpage_image] =>[orig_patent_app_number] => 12395214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558745 [patent_doc_number] => 20090270322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'G PROTEIN COUPLED RECEPTOR ANTAGONISTS AND METHODS OF ACTIVATING AND INHIBITING G PROTEIN COUPLED RECEPTORS USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/394715 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 26972 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270322.pdf [firstpage_image] =>[orig_patent_app_number] => 12394715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42790 [patent_doc_number] => 07781404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/393414 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7098 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781404.pdf [firstpage_image] =>[orig_patent_app_number] => 12393414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158524 [patent_doc_number] => 20120100182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Continuous Cell Programming Devices' [patent_app_type] => utility [patent_app_number] => 12/867426 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 26235 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100182.pdf [firstpage_image] =>[orig_patent_app_number] => 12867426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379381 [patent_doc_number] => 20090191220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'METHODS FOR THE DIAGNOSIS AND TREATMENT OF CRITICALLY ILL PATIENTS WITH ENDOTHELIN, ENDOTHELIN AGONISTS AND ADRENOMEDULLIN ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/364911 [patent_app_country] => US [patent_app_date] => 2009-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7594 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191220.pdf [firstpage_image] =>[orig_patent_app_number] => 12364911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095240 [patent_doc_number] => 20110002898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'VACCINE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/865178 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14877 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002898.pdf [firstpage_image] =>[orig_patent_app_number] => 12865178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953863 [patent_doc_number] => 20110034390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'PEPTIDES, COMPOSITIONS, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/863922 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7435 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034390.pdf [firstpage_image] =>[orig_patent_app_number] => 12863922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725716 [patent_doc_number] => 08404834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Hydroxyalkyl starch derivatives and process for their preparation' [patent_app_type] => utility [patent_app_number] => 12/747981 [patent_app_country] => US [patent_app_date] => 2008-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 37561 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650861 [patent_doc_number] => 20110300130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS' [patent_app_type] => utility [patent_app_number] => 12/747501 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23123 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300130.pdf [firstpage_image] =>[orig_patent_app_number] => 12747501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616096 [patent_doc_number] => 20100323957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'NOVEL ASSAY FOR INHIBITORS OF EGFR' [patent_app_type] => utility [patent_app_number] => 12/743218 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 20599 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323957.pdf [firstpage_image] =>[orig_patent_app_number] => 12743218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 170310 [patent_doc_number] => 07662586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/291886 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 13122 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662586.pdf [firstpage_image] =>[orig_patent_app_number] => 12291886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262720 [patent_doc_number] => 20100297135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'EPITOPE FOR NEUTRALIZING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/742467 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9876 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297135.pdf [firstpage_image] =>[orig_patent_app_number] => 12742467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285669 [patent_doc_number] => 20090099344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'REDUCING PROTEIN A LEACHING DURING PROTEIN A AFFINITY CHROMATOGRAPHY' [patent_app_type] => utility [patent_app_number] => 12/269752 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14680 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099344.pdf [firstpage_image] =>[orig_patent_app_number] => 12269752 [rel_patent_id] =>[rel_patent_doc_number] =>)